Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 19, 2022

SELL
$63.83 - $80.0 $11,106 - $13,920
-174 Reduced 3.86%
4,336 $278,000
Q1 2022

Apr 26, 2022

SELL
$76.85 - $89.45 $1,537 - $1,789
-20 Reduced 0.44%
4,510 $350,000
Q4 2021

Feb 10, 2022

SELL
$74.57 - $87.19 $2,609 - $3,051
-35 Reduced 0.77%
4,530 $389,000
Q3 2021

Oct 29, 2021

SELL
$73.77 - $83.61 $4,131 - $4,682
-56 Reduced 1.21%
4,565 $367,000
Q2 2021

Jul 29, 2021

SELL
$80.5 - $88.01 $21,493 - $23,498
-267 Reduced 5.46%
4,621 $372,000
Q1 2021

Apr 27, 2021

BUY
$76.38 - $86.03 $9,547 - $10,753
125 Added 2.62%
4,888 $412,000
Q4 2020

Feb 04, 2021

SELL
$75.39 - $82.36 $2,035 - $2,223
-27 Reduced 0.56%
4,763 $381,000
Q2 2020

Jul 20, 2020

SELL
$78.66 - $94.14 $8,101 - $9,696
-103 Reduced 2.11%
4,790 $413,000
Q1 2020

May 01, 2020

SELL
$71.57 - $93.3 $6,155 - $8,023
-86 Reduced 1.73%
4,893 $396,000
Q4 2019

Jan 17, 2020

BUY
$76.7 - $88.45 $3,068 - $3,538
40 Added 0.81%
4,979 $414,000
Q3 2019

Nov 08, 2019

SELL
$81.4 - $89.78 $7,814 - $8,618
-96 Reduced 1.91%
4,939 $433,000
Q2 2019

Aug 06, 2019

SELL
$73.44 - $82.41 $14,981 - $16,811
-204 Reduced 3.89%
5,035 $409,000
Q1 2019

May 09, 2019

SELL
$64.48 - $81.31 $35,721 - $45,045
-554 Reduced 9.56%
5,239 $425,000
Q4 2018

Feb 01, 2019

BUY
$61.45 - $77.8 $36,071 - $45,668
587 Added 11.28%
5,793 $381,000
Q3 2018

Oct 26, 2018

SELL
$70.71 - $77.75 $636 - $699
-9 Reduced 0.17%
5,206 $402,000
Q2 2018

Aug 07, 2018

BUY
$63.43 - $75.41 $8,816 - $10,481
139 Added 2.74%
5,215 $382,000
Q1 2018

May 01, 2018

BUY
$62.56 - $72.26 $3,628 - $4,191
58 Added 1.16%
5,076 $322,000
Q4 2017

Feb 12, 2018

SELL
$61.45 - $66.05 $10,323 - $11,096
-168 Reduced 3.24%
5,018 $351,000
Q3 2017

Nov 01, 2017

SELL
$59.5 - $64.61 $3,094 - $3,359
-52 Reduced 0.99%
5,186 $318,000
Q2 2017

Aug 08, 2017

BUY
N/A
5,238
5,238 $318,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Good Life Advisors, LLC Portfolio

Follow Good Life Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Good Life Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Good Life Advisors, LLC with notifications on news.